20 results on '"Iwasaki, Akiko"'
Search Results
2. Distinguishing features of long COVID identified through immune profiling
- Author
-
Klein, Jon, primary, Wood, Jamie, additional, Jaycox, Jillian R., additional, Dhodapkar, Rahul M., additional, Lu, Peiwen, additional, Gehlhausen, Jeff R., additional, Tabachnikova, Alexandra, additional, Greene, Kerrie, additional, Tabacof, Laura, additional, Malik, Amyn A., additional, Silva Monteiro, Valter, additional, Silva, Julio, additional, Kamath, Kathy, additional, Zhang, Minlu, additional, Dhal, Abhilash, additional, Ott, Isabel M., additional, Valle, Gabrielee, additional, Peña-Hernández, Mario, additional, Mao, Tianyang, additional, Bhattacharjee, Bornali, additional, Takahashi, Takehiro, additional, Lucas, Carolina, additional, Song, Eric, additional, McCarthy, Dayna, additional, Breyman, Erica, additional, Tosto-Mancuso, Jenna, additional, Dai, Yile, additional, Perotti, Emily, additional, Akduman, Koray, additional, Tzeng, Tiffany J., additional, Xu, Lan, additional, Geraghty, Anna C., additional, Monje, Michelle, additional, Yildirim, Inci, additional, Shon, John, additional, Medzhitov, Ruslan, additional, Lutchmansingh, Denyse, additional, Possick, Jennifer D., additional, Kaminski, Naftali, additional, Omer, Saad B., additional, Krumholz, Harlan M., additional, Guan, Leying, additional, Dela Cruz, Charles S., additional, van Dijk, David, additional, Ring, Aaron M., additional, Putrino, David, additional, and Iwasaki, Akiko, additional
- Published
- 2023
- Full Text
- View/download PDF
3. First encounter with SARS-CoV-2: immune portraits of COVID susceptibility.
- Author
-
Israelow, Benjamin and Iwasaki, Akiko
- Abstract
Controlled infection with SARS-CoV-2 of people who hadn’t previously been exposed to the virus reveals how molecular and cellular signatures of the immune response portend effective defence against COVID-19.Controlled human infection with SARS-CoV-2 to track defence responses. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
4. Interferon deficiency can lead to severe COVID
- Author
-
Meffre, Eric and Iwasaki, Akiko
- Subjects
Interferon -- Physiological aspects ,Deficiency diseases -- Complications and side effects ,Environmental issues ,Science and technology ,Zoology and wildlife conservation - Abstract
Understanding what contributes to the development of severe COVID-19 would be of great clinical benefit. Analysis of people in whom this occurred pinpoints a key role for the signalling pathway mediated by type I interferon proteins. Genetic and antibody clues to a cause of life-threatening illness., Author(s): Eric Meffre, Akiko Iwasaki Author Affiliations: Interferon deficiency can lead to severe COVID Infection with the SARS-CoV-2 coronavirus results in diverse outcomes for COVID-19, with the disease tending to [...]
- Published
- 2020
- Full Text
- View/download PDF
5. Access of protective antiviral antibody to neuronal tissues requires CD4 T-cell help
- Author
-
Iijima, Norifumi and Iwasaki, Akiko
- Subjects
Neurons -- Physiological aspects ,T cells -- Physiological aspects ,Viral antibodies -- Physiological aspects ,Antibodies -- Physiological aspects ,Virus diseases -- Development and progression ,Environmental issues ,Science and technology ,Zoology and wildlife conservation - Abstract
Interferon-[gamma]-secreting CD4.sup.+ helper T cells are required for antibody access to neuronal tissues in response to neurotropic virus infections. CD4 T cells enable antibody delivery to neuronal tissue Norifumi Iijima and Akiko Iwasaki investigate the mechanism of antibody-mediated protection within barrier-protected tissues using a mouse model of genital herpes infection. They find that interferon-[gamma]-secreting CD4.sup.+ helper T cells are required for antibody access to neuronal tissues in response to challenge with herpes simplex virus 2. These results point to a previously unappreciated role of CD4.sup.+ T cells in mobilizing antibodies to the peripheral sites of infection where they help to limit viral spread. Circulating antibodies can access most tissues to mediate surveillance and elimination of invading pathogens. Immunoprivileged tissues such as the brain and the peripheral nervous system are shielded from plasma proteins by the blood-brain barrier.sup.1 and blood-nerve barrier.sup.2, respectively. Yet, circulating antibodies must somehow gain access to these tissues to mediate their antimicrobial functions. Here we examine the mechanism by which antibodies gain access to neuronal tissues to control infection. Using a mouse model of genital herpes infection, we demonstrate that both antibodies and CD4 T cells are required to protect the host after immunization at a distal site. We show that memory CD4 T cells migrate to the dorsal root ganglia and spinal cord in response to infection with herpes simplex virus type 2. Once inside these neuronal tissues, CD4 T cells secrete interferon-[gamma] and mediate local increase in vascular permeability, enabling antibody access for viral control. A similar requirement for CD4 T cells for antibody access to the brain is observed after intranasal challenge with vesicular stomatitis virus. Our results reveal a previously unappreciated role of CD4 T cells in mobilizing antibodies to the peripheral sites of infection where they help to limit viral spread., Author(s): Norifumi Iijima [sup.1] , Akiko Iwasaki [sup.1] [sup.1] Author Affiliations: (1) Department of Immunobiology, Howard Hughes Medical Institute, Yale School of Medicine, New Haven, USA Main To investigate the [...]
- Published
- 2016
- Full Text
- View/download PDF
6. Mitochondrial DNA stress primes the antiviral innate immune response
- Author
-
West, A. Phillip, Khoury-Hanold, William, Staron, Matthew, Tal, Michal C., Pineda, Cristiana M., Lang, Sabine M., Bestwick, Megan, Duguay, Brett A., Raimundo, Nuno, MacDuff, Donna A., Kaech, Susan M., Smiley, James R., Means, Robert E., Iwasaki, Akiko, and Shadel, Gerald S.
- Subjects
Immune response -- Genetic aspects ,Host-virus relationships -- Genetic aspects ,Mitochondrial DNA -- Physiological aspects ,Environmental issues ,Science and technology ,Zoology and wildlife conservation - Abstract
Mitochondrial DNA stress potentiates type I interferon responses via activation of the cGAS-STING-IRF3 pathway. Mitochondria trigger innate immunity Accumulating evidence suggests that mitochondria, the organelles primarily responsible for cellular respiration and energy production, are also critical centres for antibacterial and antiviral innate immune responses. This study describes a link between mitochondrial stress and antiviral innate immunity. Specifically, mitochondrial DNA stress in herpes virus infected mice is shown to elevate interferon-stimulated gene expression, potentiate type I interferon responses and confer broad viral resistance through activation of the DNA sensor cGAS and the STING-IRF3 stress pathway. Mitochondrial DNA (mtDNA) is normally present at thousands of copies per cell and is packaged into several hundred higher-order structures termed nucleoids.sup.1. The abundant mtDNA-binding protein TFAM (transcription factor A, mitochondrial) regulates nucleoid architecture, abundance and segregation.sup.2. Complete mtDNA depletion profoundly impairs oxidative phosphorylation, triggering calcium-dependent stress signalling and adaptive metabolic responses.sup.3. However, the cellular responses to mtDNA instability, a physiologically relevant stress observed in many human diseases and ageing, remain poorly defined.sup.4. Here we show that moderate mtDNA stress elicited by TFAM deficiency engages cytosolic antiviral signalling to enhance the expression of a subset of interferon-stimulated genes. Mechanistically, we find that aberrant mtDNA packaging promotes escape of mtDNA into the cytosol, where it engages the DNA sensor cGAS (also known as MB21D1) and promotes STING (also known as TMEM173)-IRF3-dependent signalling to elevate interferon-stimulated gene expression, potentiate type I interferon responses and confer broad viral resistance. Furthermore, we demonstrate that herpesviruses induce mtDNA stress, which enhances antiviral signalling and type I interferon responses during infection. Our results further demonstrate that mitochondria are central participants in innate immunity, identify mtDNA stress as a cell-intrinsic trigger of antiviral signalling and suggest that cellular monitoring of mtDNA homeostasis cooperates with canonical virus sensing mechanisms to fully engage antiviral innate immunity., Author(s): A. Phillip West [sup.1] , William Khoury-Hanold [sup.2] , Matthew Staron [sup.2] , Michal C. Tal [sup.2] [sup.7] , Cristiana M. Pineda [sup.1] , Sabine M. Lang [sup.1] , [...]
- Published
- 2015
- Full Text
- View/download PDF
7. Inflammasome activation in infected macrophages drives COVID-19 pathology
- Author
-
Sefik, Esen, primary, Qu, Rihao, additional, Junqueira, Caroline, additional, Kaffe, Eleanna, additional, Mirza, Haris, additional, Zhao, Jun, additional, Brewer, J. Richard, additional, Han, Ailin, additional, Steach, Holly R., additional, Israelow, Benjamin, additional, Blackburn, Holly N., additional, Velazquez, Sofia E., additional, Chen, Y. Grace, additional, Halene, Stephanie, additional, Iwasaki, Akiko, additional, Meffre, Eric, additional, Nussenzweig, Michel, additional, Lieberman, Judy, additional, Wilen, Craig B., additional, Kluger, Yuval, additional, and Flavell, Richard A., additional
- Published
- 2022
- Full Text
- View/download PDF
8. Sex differences in immune responses that underlie COVID-19 disease outcomes
- Author
-
Takahashi, Takehiro, Ellingson, Mallory K., Wong, Patrick, Israelow, Benjamin, Lucas, Carolina, Klein, Jon, Silva, Julio, Mao, Tianyang, Oh, Ji Eun, Tokuyama, Maria, Lu, Peiwen, Venkataraman, Arvind, Park, Annsea, Liu, Feimei, Meir, Amit, Sun, Jonathan, Wang, Eric Y., Casanovas-Massana, Arnau, Wyllie, Anne L., Vogels, Chantal B. F., Earnest, Rebecca, Lapidus, Sarah, Ott, Isabel M., Moore, Adam J., Anastasio, Kelly, Askenase, Michael H., Batsu, Maria, Beatty, Hannah, Bermejo, Santos, Bickerton, Sean, Brower, Kristina, Bucklin, Molly L., Cahill, Staci, Campbell, Melissa, Cao, Yiyun, Courchaine, Edward, Datta, Rupak, DeIuliis, Giuseppe, Geng, Bertie, Glick, Laura, Handoko, Ryan, Kalinich, Chaney, Khoury-Hanold, William, Kim, Daniel, Knaggs, Lynda, Kuang, Maxine, Kudo, Eriko, Lim, Joseph, Linehan, Melissa, Lu-Culligan, Alice, Malik, Amyn A., Martin, Anjelica, Matos, Irene, McDonald, David, Minasyan, Maksym, Mohanty, Subhasis, Muenker, M. Catherine, Naushad, Nida, Nelson, Allison, Nouws, Jessica, Nunez-Smith, Marcella, Obaid, Abeer, Ott, Isabel, Park, Hong-Jai, Peng, Xiaohua, Petrone, Mary, Prophet, Sarah, Rahming, Harold, Rice, Tyler, Rose, Kadi-Ann, Sewanan, Lorenzo, Sharma, Lokesh, Shepard, Denise, Silva, Erin, Simonov, Michael, Smolgovsky, Mikhail, Song, Eric, Sonnert, Nicole, Strong, Yvette, Todeasa, Codruta, Valdez, Jordan, Velazquez, Sofia, Vijayakumar, Pavithra, Wang, Haowei, Watkins, Annie, White, Elizabeth B., Yang, Yexin, Shaw, Albert, Fournier, John B., Odio, Camila D., Farhadian, Shelli, Dela Cruz, Charles, Grubaugh, Nathan D., Schulz, Wade L., Ring, Aaron M., Ko, Albert I., Omer, Saad B., and Iwasaki, Akiko
- Subjects
0301 basic medicine ,Multidisciplinary ,Innate immune system ,biology ,business.industry ,T cell ,03 medical and health sciences ,030104 developmental biology ,0302 clinical medicine ,medicine.anatomical_structure ,Immune system ,Immunity ,030220 oncology & carcinogenesis ,Immunology ,biology.protein ,Medicine ,Antibody ,business ,Viral load ,Sex characteristics ,Cohort study - Abstract
There is increasing evidence that coronavirus disease 2019 (COVID-19) produces more severe symptoms and higher mortality among men than among women1-5. However, whether immune responses against severe acute respiratory syndrome coronavirus (SARS-CoV-2) differ between sexes, and whether such differences correlate with the sex difference in the disease course of COVID-19, is currently unknown. Here we examined sex differences in viral loads, SARS-CoV-2-specific antibody titres, plasma cytokines and blood-cell phenotyping in patients with moderate COVID-19 who had not received immunomodulatory medications. Male patients had higher plasma levels of innate immune cytokines such as IL-8 and IL-18 along with more robust induction of non-classical monocytes. By contrast, female patients had more robust T cell activation than male patients during SARS-CoV-2 infection. Notably, we found that a poor T cell response negatively correlated with patients' age and was associated with worse disease outcome in male patients, but not in female patients. By contrast, higher levels of innate immune cytokines were associated with worse disease progression in female patients, but not in male patients. These findings provide a possible explanation for the observed sex biases in COVID-19, and provide an important basis for the development of a sex-based approach to the treatment and care of male and female patients with COVID-19.
- Published
- 2020
9. VEGF-C-driven lymphatic drainage enables brain tumor immunosurveillance
- Author
-
Song, Eric, Mao, Tianyang, Dong, Huiping, Boisserand, Ligia Simoes Braga, Antila, Salli, Bosenberg, Marcus, Alitalo, Kari, Thomas, Jean-Leon, and Iwasaki, Akiko
- Subjects
Article - Abstract
Immune surveillance against pathogens and tumors in the central nervous system (CNS) is thought to be limited due to the lack of lymphatic drainage. However, recent characterization of the meningeal lymphatic network sheds new light on previously unappreciated ways of eliciting immune response to antigens expressed in the brain1–3. Despite the remarkable progress made in our understanding of the development and structure of meningeal lymphatics, its contribution in evoking a protective antigen-specific immune response in the brain still remains unclear. Here we examine whether meningeal lymphatic vasculature can be manipulated to mount better immune responses against brain tumors. Using a mouse model of glioblastoma multiforme (GBM), we show that very limited CD8 T cell immunity to GBM antigen is elicited when the tumor is confined to the CNS, resulting in uncontrolled tumor growth. However, ectopic VEGF-C expression promotes enhanced CD8 T cell priming in the draining deep cervical lymph nodes, migration of CD8 T cells into the tumor and rapid clearance of the GBM, resulting in long-lasting antitumor memory response. Further, VEGF-C mRNA works synergistically with checkpoint blockade therapy to eradicate existing GBM. These results reveal the capacity of VEGF-C to promote tumor immune surveillance, and offer a new therapeutic approach to treat brain tumors.
- Published
- 2020
10. KDM5B promotes immune evasion by recruiting SETDB1 to silence retroelements
- Author
-
Zhang, Shang-Min, primary, Cai, Wesley L., additional, Liu, Xiaoni, additional, Thakral, Durga, additional, Luo, Jiesi, additional, Chan, Lok Hei, additional, McGeary, Meaghan K., additional, Song, Eric, additional, Blenman, Kim R. M., additional, Micevic, Goran, additional, Jessel, Shlomit, additional, Zhang, Yangyi, additional, Yin, Mingzhu, additional, Booth, Carmen J., additional, Jilaveanu, Lucia B., additional, Damsky, William, additional, Sznol, Mario, additional, Kluger, Harriet M., additional, Iwasaki, Akiko, additional, Bosenberg, Marcus W., additional, and Yan, Qin, additional
- Published
- 2021
- Full Text
- View/download PDF
11. Reply to: A finding of sex similarities rather than differences in COVID-19 outcomes
- Author
-
Takahashi, Takehiro, primary, Ellingson, Mallory K., additional, Wong, Patrick, additional, Israelow, Benjamin, additional, Lucas, Carolina, additional, Klein, Jon, additional, Silva, Julio, additional, Mao, Tianyang, additional, Oh, Ji Eun, additional, Tokuyama, Maria, additional, Lu, Peiwen, additional, Venkataraman, Arvind, additional, Park, Annsea, additional, Liu, Feimei, additional, Meir, Amit, additional, Sun, Jonathan, additional, Wang, Eric Y., additional, Casanovas-Massana, Arnau, additional, Wyllie, Anne L., additional, Vogels, Chantal B. F., additional, Earnest, Rebecca, additional, Lapidus, Sarah, additional, Ott, Isabel M., additional, Moore, Adam J., additional, Shaw, Albert, additional, Fournier, John B., additional, Odio, Camila D., additional, Farhadian, Shelli, additional, Dela Cruz, Charles, additional, Grubaugh, Nathan D., additional, Schulz, Wade L., additional, Ring, Aaron M., additional, Ko, Albert I., additional, Omer, Saad B., additional, and Iwasaki, Akiko, additional
- Published
- 2021
- Full Text
- View/download PDF
12. A vaccine strategy that protects against genital herpes by establishing local memory T cells
- Author
-
Shin, Haina and Iwasaki, Akiko
- Subjects
Drugs -- Vehicles ,T cells -- Properties -- Observations ,Sexually transmitted disease vaccines -- Testing ,Drug delivery systems -- Testing ,Environmental issues ,Science and technology ,Zoology and wildlife conservation - Abstract
Most successful existing vaccines rely on neutralizing antibodies, which may not require specific anatomical localization of B cells. However, efficacious vaccines that rely on T cells for protection have been [...]
- Published
- 2012
- Full Text
- View/download PDF
13. CD[8.sup.+] T lymphocyte mobilization to virus-infected tissue requires CD[4.sup.+] T-cell help
- Author
-
Nakanishi, Yusuke, Lu, Bao, Gerard, Craig, and Iwasaki, Akiko
- Subjects
CD8 lymphocytes -- Health aspects -- Analysis -- Research -- Physiological aspects ,Immune response -- Research -- Physiological aspects -- Health aspects -- Analysis ,Cell migration -- Analysis -- Research -- Physiological aspects -- Health aspects ,CD4 lymphocytes -- Physiological aspects -- Health aspects -- Analysis -- Research ,Environmental issues ,Science and technology ,Zoology and wildlife conservation - Abstract
CD[4.sup.+] T helper cells are well known for their role in providing critical signals during priming of cytotoxic CD[8.sup.+] T lymphocyte (CTL) responses in vivo. T-cell help is required for [...]
- Published
- 2009
- Full Text
- View/download PDF
14. Longitudinal analyses reveal immunological misfiring in severe COVID-19
- Author
-
Lucas, Carolina, Wong, Patrick, Klein, Jon, Castro, Tiago B. R., Silva, Julio, Sundaram, Maria, Ellingson, Mallory K., Mao, Tianyang, Oh, Ji Eun, Israelow, Benjamin, Takahashi, Takehiro, Tokuyama, Maria, Lu, Peiwen, Venkataraman, Arvind, Park, Annsea, Mohanty, Subhasis, Wang, Haowei, Wyllie, Anne L., Vogels, Chantal B. F., Earnest, Rebecca, Lapidus, Sarah, Ott, Isabel M., Moore, Adam J., Muenker, M. Catherine, Fournier, John B., Campbell, Melissa, Odio, Camila D., Casanovas-Massana, Arnau, Obaid, Abeer, Lu-Culligan, Alice, Nelson, Allison, Brito, Anderson, Nunez, Angela, Martin, Anjelica, Watkins, Annie, Geng, Bertie, Kalinich, Chaney, Harden, Christina, Todeasa, Codruta, Jensen, Cole, Kim, Daniel, McDonald, David, Shepard, Denise, Courchaine, Edward, White, Elizabeth B., Song, Eric, Silva, Erin, Kudo, Eriko, DeIuliis, Giuseppe, Rahming, Harold, Park, Hong-Jai, Matos, Irene, Nouws, Jessica, Valdez, Jordan, Fauver, Joseph, Lim, Joseph, Rose, Kadi-Ann, Anastasio, Kelly, Brower, Kristina, Glick, Laura, Sharma, Lokesh, Sewanan, Lorenzo, Knaggs, Lynda, Minasyan, Maksym, Batsu, Maria, Petrone, Mary, Kuang, Maxine, Nakahata, Maura, Linehan, Melissa, Askenase, Michael H., Simonov, Michael, Smolgovsky, Mikhail, Sonnert, Nicole, Naushad, Nida, Vijayakumar, Pavithra, Martinello, Rick, Datta, Rupak, Handoko, Ryan, Bermejo, Santos, Prophet, Sarah, Bickerton, Sean, Velazquez, Sofia, Alpert, Tara, Rice, Tyler, Khoury-Hanold, William, Peng, Xiaohua, Yang, Yexin, Cao, Yiyun, Strong, Yvette, Herbst, Roy, Shaw, Albert C., Medzhitov, Ruslan, Schulz, Wade L., Grubaugh, Nathan D., Dela Cruz, Charles, Farhadian, Shelli, Ko, Albert I., Omer, Saad B., and Iwasaki, Akiko
- Subjects
Adult ,Male ,0301 basic medicine ,Chemokine ,T-Lymphocytes ,medicine.medical_treatment ,T cell ,Pneumonia, Viral ,Disease ,Article ,Pathogenesis ,Young Adult ,03 medical and health sciences ,0302 clinical medicine ,Immune system ,Cluster Analysis ,Humans ,Medicine ,Pandemics ,Aged ,Aged, 80 and over ,Interleukin-13 ,Innate immune system ,Multidisciplinary ,biology ,business.industry ,COVID-19 ,Immunoglobulin E ,Middle Aged ,Viral Load ,Eosinophils ,030104 developmental biology ,Cytokine ,medicine.anatomical_structure ,030220 oncology & carcinogenesis ,Interleukin 13 ,Immunology ,biology.protein ,Cytokines ,Female ,Interleukin-5 ,Coronavirus Infections ,business - Abstract
Recent studies have provided insights into the pathogenesis of coronavirus disease 2019 (COVID-19)1–4. However, the longitudinal immunological correlates of disease outcome remain unclear. Here we serially analysed immune responses in 113 patients with moderate or severe COVID-19. Immune profiling revealed an overall increase in innate cell lineages, with a concomitant reduction in T cell number. An early elevation in cytokine levels was associated with worse disease outcomes. Following an early increase in cytokines, patients with moderate COVID-19 displayed a progressive reduction in type 1 (antiviral) and type 3 (antifungal) responses. By contrast, patients with severe COVID-19 maintained these elevated responses throughout the course of the disease. Moreover, severe COVID-19 was accompanied by an increase in multiple type 2 (anti-helminths) effectors, including interleukin-5 (IL-5), IL-13, immunoglobulin E and eosinophils. Unsupervised clustering analysis identified four immune signatures, representing growth factors (A), type-2/3 cytokines (B), mixed type-1/2/3 cytokines (C), and chemokines (D) that correlated with three distinct disease trajectories. The immune profiles of patients who recovered from moderate COVID-19 were enriched in tissue reparative growth factor signature A, whereas the profiles of those with who developed severe disease had elevated levels of all four signatures. Thus, we have identified a maladapted immune response profile associated with severe COVID-19 and poor clinical outcome, as well as early immune signatures that correlate with divergent disease trajectories.
- Published
- 2020
- Full Text
- View/download PDF
15. Publisher Correction: VEGF-C-driven lymphatic drainage enables immunosurveillance of brain tumours
- Author
-
Song, Eric, primary, Mao, Tianyang, additional, Dong, Huiping, additional, Boisserand, Ligia Simoes Braga, additional, Antila, Salli, additional, Bosenberg, Marcus, additional, Alitalo, Kari, additional, Thomas, Jean-Leon, additional, and Iwasaki, Akiko, additional
- Published
- 2021
- Full Text
- View/download PDF
16. VEGF-C-driven lymphatic drainage enables immunosurveillance of brain tumours
- Author
-
Song, Eric, primary, Mao, Tianyang, additional, Dong, Huiping, additional, Boisserand, Ligia Simoes Braga, additional, Antila, Salli, additional, Bosenberg, Marcus, additional, Alitalo, Kari, additional, Thomas, Jean-Leon, additional, and Iwasaki, Akiko, additional
- Published
- 2020
- Full Text
- View/download PDF
17. Migrant memory B cells secrete luminal antibody in the vagina
- Author
-
Oh, Ji Eun, primary, Iijima, Norifumi, additional, Song, Eric, additional, Lu, Peiwen, additional, Klein, Jonathan, additional, Jiang, Ruoyi, additional, Kleinstein, Steven H., additional, and Iwasaki, Akiko, additional
- Published
- 2019
- Full Text
- View/download PDF
18. Impact of circulating SARS-CoV-2 variants on mRNA vaccine-induced immunity
- Author
-
Lucas, Carolina, Vogels, Chantal B. F., Yildirim, Inci, Rothman, Jessica E., Lu, Peiwen, Monteiro, Valter, Gehlhausen, Jeff R., Campbell, Melissa, Silva, Julio, Tabachnikova, Alexandra, Peña-Hernandez, Mario A., Muenker, M. Catherine, Breban, Mallery I., Fauver, Joseph R., Mohanty, Subhasis, Huang, Jiefang, Shaw, Albert C., Ko, Albert I., Omer, Saad B., Grubaugh, Nathan D., and Iwasaki, Akiko
- Abstract
The emergence of SARS-CoV-2 variants with mutations in major neutralizing antibody-binding sites can affect humoral immunity induced by infection or vaccination1–6. Here we analysed the development of anti-SARS-CoV-2 antibody and T cell responses in individuals who were previously infected (recovered) or uninfected (naive) and received mRNA vaccines to SARS-CoV-2. While individuals who were previously infected sustained higher antibody titres than individuals who were uninfected post-vaccination, the latter reached comparable levels of neutralization responses to the ancestral strain after the second vaccine dose. T cell activation markers measured upon spike or nucleocapsid peptide in vitro stimulation showed a progressive increase after vaccination. Comprehensive analysis of plasma neutralization using 16 authentic isolates of distinct locally circulating SARS-CoV-2 variants revealed a range of reduction in the neutralization capacity associated with specific mutations in the spike gene: lineages with E484K and N501Y/T (for example, B.1.351 and P.1) had the greatest reduction, followed by lineages with L452R (for example, B.1.617.2). While both groups retained neutralization capacity against all variants, plasma from individuals who were previously infected and vaccinated displayed overall better neutralization capacity than plasma from individuals who were uninfected and also received two vaccine doses, pointing to vaccine boosters as a relevant future strategy to alleviate the effect of emerging variants on antibody neutralizing activity.
- Published
- 2021
- Full Text
- View/download PDF
19. Diverse functional autoantibodies in patients with COVID-19
- Author
-
Wang, Eric Y., Mao, Tianyang, Klein, Jon, Dai, Yile, Huck, John D., Jaycox, Jillian R., Liu, Feimei, Zhou, Ting, Israelow, Benjamin, Wong, Patrick, Coppi, Andreas, Lucas, Carolina, Silva, Julio, Oh, Ji Eun, Song, Eric, Perotti, Emily S., Zheng, Neil S., Fischer, Suzanne, Campbell, Melissa, Fournier, John B., Wyllie, Anne L., Vogels, Chantal B. F., Ott, Isabel M., Kalinich, Chaney C., Petrone, Mary E., Watkins, Anne E., Dela Cruz, Charles, Farhadian, Shelli F., Schulz, Wade L., Ma, Shuangge, Grubaugh, Nathan D., Ko, Albert I., Iwasaki, Akiko, and Ring, Aaron M.
- Abstract
COVID-19 manifests with a wide spectrum of clinical phenotypes that are characterized by exaggerated and misdirected host immune responses1–6. Although pathological innate immune activation is well-documented in severe disease1, the effect of autoantibodies on disease progression is less well-defined. Here we use a high-throughput autoantibody discovery technique known as rapid extracellular antigen profiling7to screen a cohort of 194 individuals infected with SARS-CoV-2, comprising 172 patients with COVID-19 and 22 healthcare workers with mild disease or asymptomatic infection, for autoantibodies against 2,770 extracellular and secreted proteins (members of the exoproteome). We found that patients with COVID-19 exhibit marked increases in autoantibody reactivities as compared to uninfected individuals, and show a high prevalence of autoantibodies against immunomodulatory proteins (including cytokines, chemokines, complement components and cell-surface proteins). We established that these autoantibodies perturb immune function and impair virological control by inhibiting immunoreceptor signalling and by altering peripheral immune cell composition, and found that mouse surrogates of these autoantibodies increase disease severity in a mouse model of SARS-CoV-2 infection. Our analysis of autoantibodies against tissue-associated antigens revealed associations with specific clinical characteristics. Our findings suggest a pathological role for exoproteome-directed autoantibodies in COVID-19, with diverse effects on immune functionality and associations with clinical outcomes.
- Published
- 2021
- Full Text
- View/download PDF
20. CD8+ T lymphocyte mobilization to virus-infected tissue requires CD4+ T-cell help.
- Author
-
Nakanishi, Yusuke, Lu, Bao, Gerard, Craig, and Iwasaki, Akiko
- Subjects
T cells ,LYMPHOCYTES ,CELL-mediated cytotoxicity ,CHEMOKINES ,CELL death ,CYTOKINES ,INFLAMMATORY mediators ,PEPTIDES ,CELL-mediated lympholysis ,INTERLEUKIN-2 ,DISEASES - Abstract
CD4
+ T helper cells are well known for their role in providing critical signals during priming of cytotoxic CD8+ T lymphocyte (CTL) responses in vivo. T-cell help is required for the generation of primary CTL responses as well as in promoting protective CD8+ memory T-cell development. However, the role of CD4 help in the control of CTL responses at the effector stage is unknown. Here we show that fully helped effector CTLs are themselves not self-sufficient for entry into the infected tissue, but rely on the CD4+ T cells to provide the necessary cue. CD4+ T helper cells control the migration of CTL indirectly through the secretion of IFN-γ and induction of local chemokine secretion in the infected tissue. Our results reveal a previously unappreciated role of CD4 help in mobilizing effector CTL to the peripheral sites of infection where they help to eliminate infected cells. [ABSTRACT FROM AUTHOR]- Published
- 2009
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.